Active Ingredient Semaglutide (Advanced GLP-1 Receptor Agonist) Pen Strength 0.25 mg Semaglutide per Pre-filled Pen Delivery Tool Integrated Precision Dial Pre-filled Pen Primary Manufacturer Sun Pharmaceutical Industries Ltd Administration Route Subcutaneous Injection (Weekly adjustable baseline) Primary Indication Initiation Phase / Starter Cycle for Chronic Weight Management
They work by mimicking the action of the GLP-1 hormone, which regulates appetite, insulin secretion, and blood sugar levels
Reconstitution Math: From Vial to Syringe Units U-100 units, where 100 units = 1 mL
What should I expect during a Tirzepatide weight loss program
We have lab, animal, clinical, and cohort data testifying to their broad effects
Appetite suppression and craving reduction starts shortly after beginning the medication